Goldman Sachs

Goldman Sachs’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Goldman Sachs’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell
2016 Q3	$15K	Sell
2016 Q2	$74K	Buy
2016 Q1	$53K	Sell
2015 Q4	$145K	Sell
2015 Q3	$553K	Buy
2015 Q1	–	Sell
2014 Q4	$12K	Sell
2014 Q3	$299K	Sell
2014 Q2	$262K	Buy